STOCK TITAN
  1. Home
  2. Sec-filings
  3. JAZZ
  4. [144] Jazz Pharmaceuticals plc SEC Filing

Jazz Pharma officer plans $1.5M stock sale

Jazz Pharmaceuticals plc (JAZZ) officer Bruce C. Cozadd filed a Rule 144 notice for a planned sale of 6,000 shares of common stock through Merrill Lynch, with an aggregate market value of $1,500,780, expected on September 1, 2026 on NASDAQ.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) officer Bruce C. Cozadd filed a Rule 144 notice for a planned sale of 6,000 shares of common stock through Merrill Lynch, with an aggregate market value of $1,500,780, expected on September 1, 2026 on NASDAQ.

The filing also lists prior open-market sales of 6,000 shares each on June 1, July 1, and August 3, 2026.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 6,000 shares Common stock to be sold through Merrill Lynch on NASDAQ
Aggregate market value of proposed sale $1,500,780 Value associated with 6,000 shares in the planned Rule 144 sale
Proposed sale date 09/01/2026 Date listed for the Rule 144 transaction on NASDAQ
Past sale on 06/01/2026 6,000 shares for $1,410,720 Common stock sold by Bruce C. Cozadd during prior 3 months
Past sale on 07/01/2026 6,000 shares for $1,442,820 Common stock sold by Bruce C. Cozadd during prior 3 months
Past sale on 08/03/2026 6,000 shares for $1,517,880 Common stock sold by Bruce C. Cozadd during prior 3 months
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option financial
"Common | 02/26/2018 | Stock Option | Jazz Pharmaceuticals PLC"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
aggregate market value financial
"Common | Merrill Lynch ... | 6000 | 1500780 | 64914577"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing disclose for JAZZ?
It discloses that officer Bruce C. Cozadd filed a Rule 144 notice to sell 6,000 shares of Jazz Pharmaceuticals plc common stock through Merrill Lynch, with an aggregate market value of $1,500,780, expected to trade on NASDAQ on September 1, 2026.

How many JAZZ shares are proposed to be sold under this Form 144?
The notice covers a proposed sale of 6,000 shares of Jazz Pharmaceuticals plc common stock, to be sold through Merrill Lynch on NASDAQ, with an indicated aggregate market value of $1,500,780 as stated in the filing.

Who is selling JAZZ shares under Rule 144 in this filing?
The seller is Bruce C. Cozadd, identified as an officer of Jazz Pharmaceuticals plc. The filing lists him as the person for whose account the 6,000 shares of common stock are to be sold under Rule 144.

What past JAZZ stock sales by Bruce C. Cozadd are disclosed?
The filing lists three prior sales of 6,000 shares each of Jazz Pharmaceuticals plc common stock on June 1, 2026 for $1,410,720, July 1, 2026 for $1,442,820, and August 3, 2026 for $1,517,880.

What is the planned trade date and venue for the new JAZZ share sale?
The proposed sale of 6,000 shares of Jazz Pharmaceuticals plc common stock is listed with a date of September 1, 2026, with the securities to be sold on NASDAQ through Merrill Lynch.

What type of securities are underlying the JAZZ sale in this Form 144?
The filing identifies the securities as common stock of Jazz Pharmaceuticals plc. It notes that they relate to stock options granted on February 26, 2018, February 27, 2018, and March 1, 2018, with cash as the consideration method.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR